Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-84015-0, published online 01 March 2021
This Article contains an error in Figure 3 labelling of the endpoint events in Non-Acarbose users (red solid line) and Acarbose users (grey dashed line).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, XL., Yuan, SY., Wan, G. et al. Author Correction: The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24). Sci Rep 11, 10987 (2021). https://doi.org/10.1038/s41598-021-90670-0
Published:
DOI: https://doi.org/10.1038/s41598-021-90670-0
